Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,472 | 152 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $413.65 | 17 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $377.81 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $290.08 | 15 | $0 (2024) |
| PFIZER INC. | $230.10 | 15 | $0 (2024) |
| Lilly USA, LLC | $162.42 | 22 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $136.03 | 10 | $0 (2020) |
| Amgen Inc. | $129.96 | 6 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $105.16 | 6 | $0 (2018) |
| Novo Nordisk Inc | $86.42 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $61.25 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $93.63 | 5 | PFIZER INC. ($24.00) |
| 2023 | $58.53 | 3 | PFIZER INC. ($44.19) |
| 2020 | $179.37 | 10 | Amarin Pharma Inc. ($36.19) |
| 2019 | $506.82 | 29 | Boehringer Ingelheim Pharmaceuticals, Inc. ($119.24) |
| 2018 | $806.83 | 59 | AstraZeneca Pharmaceuticals LP ($140.19) |
| 2017 | $826.95 | 46 | Boehringer Ingelheim Pharmaceuticals, Inc. ($193.68) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Oncology | ||||||
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Respiratory | ||||||
| 06/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 11/01/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2023 | AbbVie Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/12/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 03/10/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular | ||||||
| 02/19/2020 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/12/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: NEUROSCIENCE | ||||||
| 02/12/2020 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug), GIVLAARI | Food and Beverage | Cash or cash equivalent | $14.21 | General |
| Category: GI | ||||||
| 01/29/2020 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT (Biological), ADACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Vaccines | ||||||
| 01/28/2020 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: VACCINE | ||||||
| 01/15/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Bone Health | ||||||
| 01/14/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Diabetes | ||||||
| 01/08/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular | ||||||
| 12/04/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: UROLOGY | ||||||
| 11/26/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2019 | Seqirus USA Inc | Fluad (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Vaccines | ||||||
| 11/07/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: VACCINES | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 10/15/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,045 | 6,345 | $708,742 | $186,839 |
| 2022 | 15 | 1,112 | 6,196 | $642,058 | $167,592 |
| 2021 | 16 | 1,206 | 6,303 | $571,981 | $175,657 |
| 2020 | 18 | 1,318 | 5,656 | $561,760 | $156,448 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 46 | 4,740 | $297,360 | $85,596 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 336 | 646 | $167,609 | $34,853 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 230 | 364 | $133,120 | $30,738 | 23.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 170 | 170 | $63,352 | $21,833 | 34.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $18,193 | $6,482 | 35.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,728 | $1,971 | 34.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 54 | 190 | $12,631 | $1,751 | 13.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 17 | 17 | $3,502 | $1,289 | 36.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 33 | 33 | $2,839 | $1,012 | 35.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $2,171 | $766.75 | 35.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 34 | 36 | $1,565 | $356.19 | 22.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 65 | 89 | $672.00 | $192.18 | 28.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 46 | 4,500 | $262,440 | $76,487 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 369 | 737 | $190,509 | $40,595 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 306 | $111,546 | $25,373 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 69 | 69 | $25,668 | $9,095 | 35.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 63 | 65 | $11,862 | $4,432 | 37.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $7,580 | $2,673 | 35.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 67 | $5,541 | $1,987 | 35.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 57 | 180 | $11,880 | $1,719 | 14.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 12 | 12 | $4,131 | $1,591 | 38.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 36 | 36 | $4,068 | $1,410 | 34.7% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 23 | 23 | $2,359 | $908.91 | 38.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $1,603 | $689.20 | 43.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 31 | 32 | $1,376 | $321.59 | 23.4% |
About Dr. Erin Dawson, MD
Dr. Erin Dawson, MD is a Family Medicine healthcare provider based in Port Orchard, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386652063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Erin Dawson, MD has received a total of $2,472 in payments from pharmaceutical and medical device companies, with $93.63 received in 2024. These payments were reported across 152 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,472).
As a Medicare-enrolled provider, Dawson has provided services to 4,681 Medicare beneficiaries, totaling 24,500 services with total Medicare billing of $686,537. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Port Orchard, WA
- Active Since 08/04/2006
- Last Updated 02/10/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386652063
Products in Payments
- FARXIGA (Drug) $200.20
- PREVNAR - 13 (Biological) $114.36
- SPIRIVA RESPIMAT (Drug) $107.75
- EVENITY (Biological) $98.12
- SPIRIVA (Drug) $94.49
- ADVAIR (Drug) $87.40
- TRULICITY (Drug) $85.79
- SYMBICORT (Drug) $82.88
- JANUVIA (Drug) $80.77
- STIOLTO RESPIMAT (Drug) $78.75
- STIOLTO (Drug) $75.93
- ELIQUIS (Drug) $68.19
- MYRBETRIQ (Drug) $61.25
- BREO (Drug) $57.34
- SOLIQUA (Drug) $53.99
- COSENTYX (Biological) $53.35
- ANORO (Drug) $52.35
- FORTEO (Drug) $51.32
- BEVESPI AEROSPHERE (Drug) $48.90
- MYDAYIS (Drug) $42.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Port Orchard
Christine Lomotan, M.d, M.D
Family Medicine — Payments: $25,916
Dr. Brad Frandsen, Md, MD
Family Medicine — Payments: $5,014
Dr. Michael Mccord, M.d, M.D
Family Medicine — Payments: $2,188
Dr. Christopher Quarles, Md, MD
Family Medicine — Payments: $641.14
Dr. Samay Jain, M.d, M.D
Family Medicine — Payments: $522.73
Melissa Meyer, M.d, M.D
Family Medicine — Payments: $252.71